ELIC — Elicera Therapeutics AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK249.77m
- SEK214.84m
- SEK7.13m
Annual cashflow statement for Elicera Therapeutics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.83 | -13.1 | -19.4 | -17.1 | -16.9 |
| Amortisation | |||||
| Changes in Working Capital | 1.91 | -1.19 | 10.8 | 2.16 | -6.59 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.905 | -14.3 | -8.57 | -14.9 | -23.5 |
| Capital Expenditures | -0.059 | — | — | -0.001 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.05 | -0.001 | 0 | 0.484 | 0 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | -0.009 | -0.001 | 0 | 0.483 | 0 |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 12.4 | 55.1 | 0 | 0 | 20.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 11.5 | 40.8 | -8.57 | -14.4 | -2.98 |